The epidemiologic literature in the English language regarding intake of tomatoes and tomato-based products and blood lycopene (a compound derived predominantly from tomatoes) level in relation to the risk of various cancers was reviewed. Among 72 studies identified, 57 reported inverse associations between tomato intake or blood lycopene level and the risk of cancer at a defined anatomic site; 35 of these inverse associations were statistically significant. No study indicated that higher tomato consumption or blood lycopene level statistically significantly increased the risk of cancer at any of the investigated sites. About half of the relative risks for comparisons of high with low intakes or levels for tomatoes or lycopene were approximately 0.6 or lower. The evidence for a benefit was strongest for cancers of the prostate, lung, and stomach. Data were also suggestive of a benefit for cancers of the pancreas, colon and rectum, esophagus, oral cavity, breast, and cervix. Because the data are from observational studies, a cause-effect relationship cannot be established definitively. However, the consistency of the results across numerous studies in diverse populations, for casecontrol and prospective studies, and for dietary-based and blood-based investigations argues against bias or confounding as the explanation for these findings. Lycopene may account for or contribute to these benefits, but this possibility is not yet proven and requires further study. Numerous other potentially beneficial compounds are present in tomatoes, and, conceivably, complex interactions among multiple components may contribute to the anticancer properties of tomatoes. The consistently lower risk of cancer for a variety of anatomic sites that is associated with higher consumption of tomatoes and tomato-based products adds further support for current dietary recommendations to increase fruit and vegetable consumption. [J Natl Cancer Inst 1999;91:
a carotenoid consumed largely from tomatoes, have raised interest in the tomato as a food with potential anticancer properties (8) . Higher consumption of tomatoes is in fact compatible with current general recommendations aimed at increasing intake of fruits and vegetables. Nonetheless, whether unique benefits derive from tomatoes is important to establish because tomatoes are used in many processed items that are not necessarily identified with fruit or vegetable consumption. These items include tomato and spaghetti sauce, tomato soup, salsa, ketchup, and tomato paste. Moreover, many of these processed foods are better sources of bioavailable lycopene than are fresh tomatoes (9) (10) (11) .
This review examines the epidemiologic evidence regarding consumption of tomato and related products with the risk of cancer at various body sites. The main purposes of this review are to assess the evidence for benefits by specific cancer site and to consider the strengths and limitations of the studies that help indicate whether observed associations are causal. Criteria considered include the strength of any associations, consistency of results by study design (case-control or cohort), method of exposure assessment (questionnaire or biomarker), the factors controlled for by matching or through data analysis, and the potential for residual or uncontrolled confounding. The potentially beneficial constituents of tomatoes and the implications for current dietary recommendations are then discussed.
REVIEW OF EPIDEMIOLOGIC STUDIES
All human studies reported in the English language of tomatoes or lycopene in relation to the risk of any cancer were considered. These studies were found in the MEDLINE® or CAN-CERLIT® databases and in several extensive reviews (3) (4) (5) , or they were referenced in the identified studies. Because tomato intake or blood lycopene level was frequently one of numerous dietary factors examined, epidemiologic reports that had fruits, vegetables, or carotenoids as key words were scrutinized for results regarding tomato or lycopene. Two general types of study designs have been used to examine lycopene and tomato products in relation to risk of cancer. One study design has been based on a dietary questionnaire, used either to assess tomato products directly or to infer lycopene consumption; the other study design has been based on measuring levels of carotenoids in stored blood samples. Studies were summarized by type of design, years conducted, country, number of cases, main exposure assessment, relative risk (RR) with P values (two-sided) or confidence intervals (CIs), and covariates controlled for by matching or in analyses. The summarized RR is that for the cancer rate in the highest intake of tomatoes or level of lycopene divided by the rate in the lowest intake or plasma level. In case-control studies, the odds ratio was used to estimate the RR.
TOTAL CANCER
Only one study has reported on tomato intake in relation to total cancer risk. In this prospective study by Colditz et al. (12) , based on 42 cancer deaths among 1271 elderly persons, individuals who were in the top half of tomato consumption had a lower risk of all cancers combined compared with those in the bottom half (RR ‫ס‬ 0.5; 95% CI ‫ס‬ 0.3-0.8). Other items, including green and yellow vegetables and strawberries, were also associated with a decreased risk of total cancer. Carrots and squash were unrelated to risk. There were too few cancers to allow examination of specific cancer sites.
LUNG AND PLEURAL CANCERS
One of the cancer sites for which a benefit of fruits and vegetables has been most apparent is for cancers of the lung (3), the leading cause of cancer death worldwide. Initial findings led investigators to focus on ␤-carotene and provided the impetus to examine supplemental ␤-carotene in relation to the risk of lung cancer in intervention trials. Unfortunately, the results from several trials either have been inconclusive (13) or have even indicated that smokers randomly assigned to receive ␤-carotene are at higher risk for lung cancer (14, 15) .
Although the focus has been on ␤-carotene, the literature shows that several fruit and vegetable groups, including leafy green and yellow/orange vegetables, are associated with a lower risk of lung cancer (3) . Fourteen studies (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) have reported specifically on tomato or lycopene consumption in relation to lung cancer risk; of these, 10 (17,18,20-24,26-28) suggest either a statistically significant or a suggestive inverse association (Table 1) . These studies, mostly case-control in design, generally adjusted for smoking history, the most important potential confounder for lung cancer. An additional study (30) indicated that higher prediagnostic dietary intake of tomatoes (recalled after diagnosis) among lung cancer case subjects was associated with better survival from lung cancer ( Table 1) . One study (22) found an inverse association between tomato intake and squamous cell and small-cell lung cancer but not with other histologic types. Statistically significant associations were observed in multiple U.S. populations, China, and Spain, and nonstatistically significant inverse associations were noted in the U.K., Norway, and Finland.
A case-control study in Hawaii by Le Marchand et al. (17) found tomato intake related to a substantially reduced risk of lung cancer; however, the same case-control dataset analyzed several years later for lycopene intake (16) indicated only a modest inverse association between lycopene intake and lung cancer risk that was not statistically significant. In this population, tomatoes accounted for only 29% of the reported lycopene intake. The conflicting results for tomato and lycopene intakes suggest that the benefit of tomatoes is related to compounds other than lycopene or that lycopene from non-tomato sources is not readily bioavailable.
Only one study that reported on mesothelioma (cancer of the pleura or peritoneum) was identified (31) . Overall, a 40% reduction in risk was noted for those consuming tomato or tomato juice 16 or more times a month versus nonconsumers. Only 1.7% of control subjects reported not consuming tomatoes or tomato juice as opposed to 9% of case subjects, suggesting nonconsumers of tomato products to be at relatively high risk for mesothelioma.
STOMACH CANCER
Although becoming relatively uncommon in most economically developed countries, stomach or gastric cancer remains one of the major causes of cancer death in the world. Twelve casecontrol studies from a variety of populations, including the United States [New York (32) , Louisiana (33) , and Hawaiian Japanese (34) ], Japan (35) , Israel (36) , , Spain (40, 41) , Poland (42) , Belgium (43) , and Sweden (44) have reported data on tomato or lycopene intake and stomach cancer risk (Table 2) . Inverse associations between tomato consumption and risk of gastric cancer were observed in all these diverse populations except for Spain (40, 41) and Japan (35) . A suggestive, but not statistically significant, inverse association was observed in a study conducted in Belgium (43) , but this study population had a very low consumption of tomatoes. An ecologic study in Japan (45) that examined plasma levels of various nutrients in samples of populations in various regions found that regions high in plasma lycopene had the lowest gastric cancer rates and regions low in lycopene had the highest rates. While other fruits and vegetables have frequently been inversely associated with gastric cancer, inverse associations with tomatoes have been among the most consistent and strongest (36) (37) (38) (39) 44) . Although no prospective studies of tomato intake and gastric cancer were identified, the consistent inverse association observed in diverse populations strongly suggests a protective effect of tomato or lycopene consumption on gastric cancer.
COLORECTAL CANCER
Cancers of the colorectum are common in economically developed areas. Five studies (37, (46) (47) (48) (49) (50) have reported on tomato intake in relation to colorectal cancer risk (Table 3) . One study in the United States (46) reported statistically significant inverse associations between tomato consumption and colon cancer risk for men and women. A study in Belgium (48) found no overall association but did find a suggestion of an inverse association between consumption of tomato puree and colon cancer risk. The consumption of tomato products was low in this population, and the contrast was ever versus never consumption; the impact of higher intakes could not be assessed. Case-control studies in Italy (37, 50) and China (49) reported about a 60% reduction in risk of both colon and rectal cancers associated with higher tomato consumption. In a rodent model of N-methylnitrosoureainduced colonic aberrant crypt foci, lycopene and lutein, but not ␤-carotene, in relatively small doses demonstrated efficacy against this premalignant lesion (51).
ORAL/LARYNGEAL/PHARYNGEAL CANCER
Only three case-control studies (52) (53) (54) have reported on tomato intake in relation to oral cancers (Table 3) . One study in China (52) reported that high consumption of tomatoes was related to approximately half the risk of oral cancer. A similar finding was observed between tomato consumption and cancers 
ESOPHAGEAL CANCER
Esophageal cancers have received little study regarding tomatoes and lycopene (Table 3) . One study in Iran (55) , which has extremely high rates of esophageal cancer particularly in men, found a 39% statistically significant reduction in risk for men who consumed tomatoes frequently, but no relationship was apparent for women. The only other diet-based study reported for this cancer, conducted in the United States (56) , reported a 30% nonstatistically significant reduction in esophageal cancer risk associated with high tomato consumption in men. A serum bank-based study by Nomura et al. (57) reported that case patients with oral, laryngeal, or esophageal cancers had a 5% lower mean prediagnostic serum lycopene level than control subjects that was not statistically significant; however, on the basis of only 28 case patients with esophageal cancer, case patients had a 16.4% lower lycopene level (P ‫ס‬ .08).
PANCREATIC CANCER
Four studies (58) (59) (60) (61) have examined tomato or lycopene status in relation to risk of pancreatic cancer; all of these studies support an inverse association (Table 3) . Two studies (58, 61) reported an inverse association but did not provide estimates of Age, sex, socioeconomic status *Relative risk and 95% confidence interval or P value (two-sided) for exposure comparison indicated; in some cases, measures other than the relative risk were given. NS ‫ס‬ not significant. RR. The two that reported the magnitude of the RR found about a fourfold to fivefold risk elevation among low consumers of tomatoes (60) or among those with low levels of serum lycopene collected prospectively in a case-control study nested within a cohort (59) . Although the serum-based study (59) involved only 22 case patients, the results were statistically significant (P<.02), and no association was seen with total carotenoids or ␤-carotene. It is unlikely that low lycopene levels were the result of the cancer because the relationship was apparent in cancers diagnosed 9-12 years after collection of the blood and pancreatic cancers are rapidly progressive and thus have a short latent period. Also suggestive of a specific effect of lycopene among carotenoids, the dietary-based study by Bueno de Mesquita et al. (60) did not find a benefit of carrots, a major source of ␤-carotene and ␣-carotene.
PROSTATE CANCER
Four cohort studies (62) (63) (64) (65) report data on the relationship between tomato or lycopene consumption and prostate cancer risk (Table 4 ). In a cohort of 14 000 Seventh-day Adventist men (62) , only tomato intake and intake of beans, lentils, and peas were statistically significantly related to lower prostate cancer risk in a multivariate analysis. ␤-Carotene-rich foods were unrelated to risk. In a larger, more comprehensive dietary study (64) , intake of the carotenoids ␤-carotene, ␣-carotene, lutein, and ␤-cryptoxanthin was not associated with risk of prostate cancer, but high lycopene intake was related to a statistically significant 21% reduction in risk. High intake of tomatoes and tomato products, which accounted for 82% of lycopene, reduced risk of total prostate cancer by 35% and aggressive prostate cancer by 53%. Tomato sauce had the strongest inverse association with prostate cancer risk (RR ‫ס‬ 0.66; 95% CI ‫ס‬ 0.49-0.90; P for trend ‫ס‬ .001), and weaker inverse associations were observed with tomatoes and pizza, but none with tomato juice. Preliminary results from two other cohort studies (63, 65) also support this finding.
One case-control study conducted in Minnesota (66) found an inverse association between tomato intake and risk of prostate cancer that was not statistically significant. In another casecontrol study conducted in a multiethnic population in Hawaii (67) , no association was found with consumption of "tomatoes." However, the intake levels were not indicated, and it did not appear that tomato-based products such as tomato sauce were specifically addressed. A case-control study conducted in the U.K. (68) found no association between raw or cooked tomatoes and risk of prostate cancer. Of note, the strongest dietary association found in that study was for baked beans (RR ‫ס‬ 0.52; 95% CI ‫ס‬ 0.31-0.88); the authors suggest that tinned baked beans may provide highly bioavailable lycopene from the tomato sauce.
Three studies (69) (70) (71) have examined serum carotenoids using prediagnostic samples in relation to prostate cancer risk. The first study (69) , which was based on serum obtained in 1974 from 25 802 persons in Washington County, MD, found a 6.2% lower median lycopene level in prostate cancer case subjects diagnosed during 13 years compared with age-and racematched control subjects. The estimated RR was 0.50 (95% CI ‫ס‬ 0.20-1.29) between high and low quartiles of lycopene. No other carotenoid was associated with prostate cancer risk. Preliminary results from the Physicians' Health Study (70) , which was based on 581 case subjects, found a statistically significant RR of 0.56 (95% CI ‫ס‬ 0.34-0.91) when comparing high quintile with low quintile of plasma lycopene.
A serum-based study conducted during the period from 1971 through 1993 in a Japanese-American population in Hawaii (71) did not detect any association between serum lycopene levels and risk of prostate cancer. However, several characteristics of the study may have contributed to the lack of an association, including use of a single assessment of serum lycopene to characterize follow-up for up to a 22-year period (only 14 cases occurred within the first 5 years of follow-up), inclusion of "low virulence" disease (28% were diagnosed incidentally during surgery for benign prostatic hyperplasia), and very low serum lycopene levels [the median serum concentration among control subjects was only 134 ng/mL, compared with 320 ng/mL in the study by Hsing et al. (69) and 424 ng/mL in the sample of 121 health professionals (64) ]. Ethnic differences in prostate cancer etiology may also be important, inasmuch as men of Asian descent may have an inherently low susceptibility to prostate cancer.
BLADDER CANCER
Four reports of tomato or lycopene consumption (72) (73) (74) or serum lycopene (75) and risk of bladder cancer were identified ( Table 4) . None of these studies found statistically significant associations with risk of bladder cancer, although tendencies for inverse associations were noted. Results from the sole serumbased study (75) were suggestive of an inverse trend (RR ‫ס‬ 0.5; P for trend ‫ס‬ .06). However, that study was based on only 35 case subjects. Unpublished data from a prospective cohort study of male health professionals do not indicate any association between consumption of tomato-based products or lycopene and bladder cancer (251 cases). A strong inverse association between tomato-based product intake and risk of prostate cancer was found in the same cohort (64) . In a rat model of urinary superficial bladder cancer induced by nitrosamines, lycopene demonstrated modest anticancer properties (76) .
BREAST CANCER
For breast cancer, a common cause of cancer in Western countries, an overall benefit of fruits and vegetables is suggested but is not as clearly apparent as for several other cancer sites (3, 4) . Considering the importance of this disease, relatively few studies have examined its relationship to tomato or lycopene intake (Table 5) . Dietary-based studies (77) (78) (79) (80) do not support an association between tomato intake and risk of breast cancer, although relatively few studies have reported on this. However, of four studies (81-84) based on biomarkers (blood level or breast adipose level) of lycopene, three (81, 82, 84 ) support a benefit, two of which were statistically significant (81, 82) . The small study (81) based on adipose levels of carotenoids in breast tissue from case and control subjects did find statistically significantly lower concentrations of lycopene among case subjects, although an impact of the cancer on tissue lycopene levels cannot be excluded. Of note, breast adipose tissue lycopene was weakly correlated with lycopene intake estimated by a foodfrequency questionnaire in that study (r ‫ס‬ .17). It is possible that a low correlation between reported intake and tissue level, whether due to measurement or biologic reasons, could account for the generally null results from dietary studies for breast cancer. Lycopene also has been shown to have antiproliferative effects against breast cancer cells in culture (85) , and tomato oleoresin-treated rats developed fewer 7,12-dimethyl-benz[a]anthracene-induced mammary tumors, whereas ␤-carotene had no effect (86) .
CERVICAL CANCER AND PRECURSORS
Two studies have reported on tomato consumption and risk of cervical cancer (87, 88) , and three have examined serum lycopene in relation to cervical cancer (89, 90) or precursor lesions (91) ( Table 5 ). Monthly tomato consumption was higher in control subjects than in case subjects in one case-control study (87) , although this finding did not attain statistical significance. A study in The Netherlands (88) found women who consumed tomatoes three or more times a week to have a 40% reduction in Age, sex, county, smoking status, calories *Relative risk and 95% confidence interval or P value (two-sided) for the exposure comparison indicated; in some cases, measures other than the relative risk were given. NS ‫ס‬ not significant. (90, 91) . In one study (90) , levels of serum carotenoids were also related to lower risk, whereas the study by VanEenwyk et al. (91) found benefits only for lycopene.
OVARIAN CANCER
Only one study that reported data regarding tomato or lycopene and ovarian cancer was found. This was a prospective serum-based study of 35 case subjects (Table 5 ) (92) . This small study indicated no association, although the mean level of serum lycopene in the case subjects was 7.4% lower than in the control subjects. More study of this cancer is clearly required before firmer conclusions can be reached.
SUMMARY OF EPIDEMIOLOGIC EVIDENCE

Consistency of Results
Including studies that have reported results but did not specify RRs, 72 studies have reported on intake of tomatoes, tomato-based products, and lycopene or blood or tissue level of lycopene and risk of a cancer site. These were based on 66 reports, some of which separately analyzed various cancer sites (e.g., colon and rectum). Of these 72 studies, 57 found inverse associations between tomato or lycopene consumption or blood lycopene level and risk of cancer; 35 of these inverse associations were statistically significant. The remaining 15 studies were inconclusive or indicated a slight direct association, with RRs mostly within the range between 1.0 and 1.2. No statistically significant direct association between tomato or lycopene consumption and risk for any cancer site was noted. Table 6 shows the RRs from 61 studies that provide data; there are 74 RRs because some studies present results stratified by sex, racial or ethnic group, colon and rectum cancers separately, and results both for blood lycopene level and for dietary tomato or lycopene intakes. Almost half the studies found RRs around 0.6 or less, about two thirds with RRs less than 0.8. The results did not vary appreciably whether they were based †From 61 studies that provided data (17) (18) (19) (20) (22) (23) (24) (25) (26) (27) (28) (29) 31, (33) (34) (35) (36) (37) (39) (40) (41) (42) (43) (44) (47) (48) (49) (52) (53) (54) (55) (56) 59, 60, (62) (63) (64) (65) (66) (67) (68) (69) (70) (71) (72) 74, 75, (77) (78) (79) (80) (81) (82) (83) (84) 86, (88) (89) (90) (91) (92) ; there are 74 relative risks because some studies present results stratified by sex, racial or ethnic group, colon and rectum cancers separately, and results both for blood lycopene level and for dietary tomato or lycopene intakes. 16 (P<.02) , 0.26 (P ‫ס‬ .004), 0.32 (P<.05), 0.37 (P ‫ס‬ .01), 0.4 (P ‫ס‬ .08), 0.5 (P ‫ס‬ .02), 0.5 (P ‫ס‬ .06), 0.50 (P ‫ס‬ .26), 0.56 (P ‫ס‬ .05), 0.62 (not significant), 1.01 (P ‫ס‬ .97), 1.0 (not significant), 1.1 (P ‫ס‬ .86), 1.14 (P ‫ס‬ .69), and 1.36 (P ‫ס‬ .59). Of these 15 studies, 10 had RRs less than or equal to 0.62, and eight were statistically significant or of borderline statistical significance (Pഛ.08), and in five of the studies (59, 69, 70, 75, 91) , an inverse relationship was limited to lycopene among carotenoids.
Comparisons by sex tended to show more studies with inverse associations for males, but most studies also supported a benefit for women (Table 6) . Cancers, such as those of the lung or stomach, for which both sexes are at risk, do not indicate strong differences in findings by sex. Evidence for a benefit was strong for prostate cancer. For several female-associated cancers, particularly cancers of the ovary and endometrium, data are very sparse.
RR estimates for the various cancers are shown in Fig. 1 . The tendency for an inverse association between consumption of tomatoes or tomato products or lycopene levels is observed for a variety of cancer sites. The data are most compelling for cancers of the prostate gland, lung, and stomach. Data are also suggestive for several other cancers, including pancreatic, colorectal, esophageal, oral, breast, and cervical cancers. Data regarding the relationship between tomato consumption or lycopene level and cancer risk for other cancer sites are too limited at present to support firm conclusions.
In summary, the epidemiologic data indicate that high consumers of tomatoes and tomato products are at substantially decreased risk of numerous cancers, although probably not all cancers. The results are consistent for a variety of cancers across numerous diverse populations and with the use of different types of study designs. These include ecologic, case-control dietary studies, prospective dietary studies, and blood specimen-based investigations. Because the evidence available is based on observational studies, and thus causality cannot be directly inferred, the possibility for biases and confounding is considered next.
Potential for Bias and Confounding as Explaining the Results
Biases occur when, through faulty data-collection techniques, the associations in the study population are distorted. For example, in some case-control studies, for which the disease status is known at the time of interview, case subjects may recall past diet differently from control subjects. Biases possibly may have occurred in specific settings, but that a single, strong methodologic bias accounts for all these findings is not plausible. Recall biases, for instance, cannot account for associations observed in prospective studies, particularly those based on blood levels of lycopene rather than on dietary recall.
Publication bias (e.g., results reported in the literature only from studies that found a relationship) is unlikely to be of major importance for our overall findings because, if no underlying association existed, one would expect as many direct associations as inverse associations to be reported. Here, 35 statistically significant inverse associations were identified, but none with direct associations were found. However, for specific cancer sites for which only a small number of reports have been published, selective publication may be a potential factor.
Although systematic errors or bias in reporting tomato or lycopene intake cannot account for all the findings, it is possible that the association between high tomato consumption and lower risk for numerous cancers is not causal but rather is secondary to some confounding factor(s) associated with tomato intake. This possibility cannot be ruled out entirely, but it is unlikely for several reasons. For confounding to occur, the confounding factor has to be simultaneously an important risk or protective factor for that cancer and correlated substantially with tomato intake. As shown in the tables, known or suspected risk factors were controlled for in many of the studies. In general, confounding from the considered factors did not account for the observed relationships.
It is possible that some unidentified confounding factor accounted for these associations. However, given the variety of cancers studied, the different etiologies for cancers, and the diversity of populations studies, uncontrolled confounding is unlikely to account for most of the inverse associations with tomatoes or lycopene. The pattern of potentially confounding factors for tomato products will likely vary among cancers, which have different risk factors. Moreover, dietary patterns differ among countries, and at least one statistically significant inverse association for tomato products was observed in 10 countries (United States, Italy, Holland, Spain, Sweden, Poland, Australia, Iran, China, and Japan). The pattern of covariates will also likely vary by type of tomato product. For example, in the Health Professionals Follow-up Study (64) , fresh tomatoes tended to be associated with "healthy" lifestyle practices, tomato sauce displayed no discernible pattern, and pizza was associated slightly with "unhealthy" practices, yet all three items were inversely associated with risk of prostate cancer.
The inverse association between plasma lycopene level and cancers of the prostate, lung, cervix, breast, and pancreas is particularly interesting because plasma and tissue lycopene levels are poorly correlated with overall vegetable and fruit intake because of the diverse nature of tomato products [r ‫ס‬ .11 (93) ; r ‫ס‬ .11 in women and .16 in men (94) ]. Unlike lycopene levels, most other carotenoid levels correlate reasonably well with vegetable and fruit intake (93, 94) . Furthermore, in a study of a general U.S. population, lower serum concentrations of ␤-carotene, ␣-carotene, lutein, and ␤-cryptoxanthin were generally associated with male sex, higher alcohol intake, increased smoking, and higher body mass index; dietary and serum lycopene levels were not associated with these factors (95) . Thus, it is unlikely that the inverse association between plasma lycopene level and risk of various cancers is a result of lycopene's being a nonspecific marker of fruit and vegetable intake or related "healthy" behaviors.
Dose-Response Relationship
Although most studies indicate an anticancer benefit of tomato consumption, it is difficult to draw firm conclusions regarding the dose-response relationship. For the most part, RRs appeared to decrease proportionally to increasing intake of tomatoes or related products. Within the observable range, there was no firm evidence of an intake level where the trend toward decreasing risk begins to reverse, although few data are available regarding intakes of tomatoes or tomato-based products exceeding one serving per day. Caution is advisable regarding pharmacologic doses of lycopene because all of the epidemiologic data are based on typical dietary intakes. Moreover, one animal study of lung cancer (96) suggests a benefit of lycopene intake at lower levels but possibly an adverse effect of lycopene intake at very high levels. Benefits may also vary by the specific type of tomato products because processing and cooking may influence the level or bioavailability of the bioactive compounds (e.g., lycopene).
POTENTIALLY BENEFICIAL ASPECTS OF TOMATOES AND TOMATO-BASED PRODUCTS
Tomato and tomato-based products are important sources of many established nutrients and are predominant sources of some phytochemicals that may have health benefits. Tomatoes are relatively rich sources of folate, vitamin C, vitamin A, and potassium. Because other good sources of these nutrients are available, the relative importance of tomatoes as contributors of these nutrients varies across populations. In the United States, consumption of tomatoes and tomato products ranks number two to potatoes among vegetables (97) . Because they are highly consumed, tomatoes and related products rank as the number three contributor of vitamin C and the number four contributor of provitamin A and are the ninth highest contributor of potassium to the U.S. diet. In Italy, tomatoes have been estimated as the second most important source of vitamin C after oranges (98) . In contrast, tomato consumption in some populations appears to be too low for them to be a good source of these nutrients [e.g., the study by Tuyns et al. (43) in Belgium]. Anticancer properties for several of these nutrients have been hypothesized.
In addition to being a substantial source of some traditional nutrients, tomatoes are rich in several phytochemicals believed to have anticancer properties. Among the most prominent phytochemicals in tomatoes are the carotenoids, important pigments found in plants, and photosynthetic bacteria, fungi, and algae. These organisms synthesize phytoene, a 40-carbon molecule with 9 double bonds (in the trans configuration), which serves as a precursor for more than 600 carotenoids. A series of desaturation steps leads sequentially to phytofluene, -carotene, neurosporene, and lycopene, a symmetrical, acyclic 40-carbon molecule with 13 double bonds (11 conjugated) . Enzymatic cyclization of the end groups of lycopene results in ␥-carotene (one ␤-ionone ring) and ␤-carotene (two ␤-ionone rings). The ␤-ionone rings are critical for vitamin A activity; other ring structures formed are devoid of vitamin A activity. Thus, cleavage of ␥-carotene forms one vitamin A molecule, while cleavage of ␤-carotene leads to two vitamin A molecules. Oxygenation of the ␤-ionone rings leads to the more polar oxycarotenoids or xanthophils, such as ␤-cryptoxanthin (one oxygenated ring, half the provitamin A activity of ␤-carotene) and lutein (two oxygenated rings and hence no provitamin A activity).
Plants vary substantially in their overall production of carotenoids and in the activities of various enzymes involved in desaturation, cyclization, and oxygenation to produce a wide range of carotenoids. For example, the red color of tomatoes results from lycopene, suggesting that red tomatoes have insufficient cyclase activity to convert lycopene to ␥-carotene and ␤-carotene efficiently. Variation in different strains of tomatoes exists, as evidenced by yellow tomatoes, which are relatively low in lycopene. Among foods typically consumed by humans, tomatoes are a particularly rich source of several carotenoids. Of 14 carotenoids found in human serum, tomato and tomato-based products contribute to nine and are the predominant source of about half of the carotenoids (99) . Tomatoes are low in ␤-carotene (most of the provitamin A activity from tomatoes is from ␥-carotene) and low in the polar xanthophils, but they are by far the major source of the remaining nonpolar carotenoids.
Overall, tomatoes are an important source of several nutrients and a predominant source of several carotenoids, particularly lycopene. Very few items other than tomato products contribute to dietary lycopene; these include watermelon, pink grapefruit, and apricots. Tomatoes are also a source of other potentially beneficial phytochemicals, including phenylpropanoids (phenolic acids), phytosterols, and flavonoids (97) . However, the biologic relevance of these latter compounds, plus the relative importance of tomatoes as a dietary source of these, is unknown.
BIOLOGIC PLAUSIBILITY OF AN ANTICANCER EFFECT OF LYCOPENE
Lycopene has received the most attention, but whether apparent anticancer properties of tomatoes result from lycopene remains unproven. Nonetheless, lycopene has several notable characteristics that may confer potentially beneficial properties. Because lycopene is not converted to vitamin A, it may be entirely available for other properties (e.g., antioxidation). The lack of the ␤-ionone ring structure for lycopene may increase its antioxidant activity (100). The stereochemical properties of lycopene are quite different from those of other commonly consumed carotenoids (101) , making it uniquely present in specific subcellular environments. Lycopene appears to be the most efficient quencher of singlet oxygen and free radicals among the common carotenoids in vitro (8, (102) (103) (104) . In some populations, lycopene is the predominant carotenoid in plasma (105) (106) (107) and in various tissues (108, 109) .
The unique biochemical properties of lycopene may render it able to protect cellular components against specific types of damage from highly reactive oxygen species. The source of the reactive compounds differs by tissue type and includes smoking, sunlight, chronic inflammation, and normal metabolic processes (110) (111) (112) . For example, smokers' lungs are exposed to high levels of nitric oxide (NO), which can react with oxygen to produce the NO 2 и radical. NO 2 radicals survive for long enough in fresh smoke to reach lung tissue (113) . Lycopene is one of the major carotenoids found in lung tissue, and concentrations vary widely among individuals (114) . Using an in vitro assay, Böhm et al. (115) showed that carotenoids are effective in protecting lymphocytes from NO 2 radical damage and that lycopene was at least twice as effective as ␤-carotene. Lycopene was shown to possess anticancer properties in a mouse lung carcinogenesis model (96) .
Chronic infection by Helicobacter pylori is a major established risk factor for gastric cancer. Chronic infections may increase cancer risk by increasing the oxidative load (116) . Elevated DNA oxidation occurs early during H. pylori infection (117) . Dietary antioxidants, including lycopene, may potentially reduce the impact of oxidative load from H. pylori infections in the stomach. Another potential contributing factor to stomach cancer is the endogenous formation of N-nitrosamines. Vitamin C has been considered to be an inhibitor of the nitrosation that generates N-nitrosamines. It is interesting that an ecologic study in Japan (45) , an area with a high incidence of stomach cancer, showed no association between average plasma vitamin C level and stomach cancer, and, in fact, the area with the lowest gastric cancer incidence had the lowest vitamin C level. In contrast, plasma lycopene level was associated with stomach cancer rate more so than the levels of other "antioxidant" nutrients assessed (vitamins A, C, and E and ␤-carotene) (45) . A study of determinants of endogenous generation of N-nitrosamine in rats (118) suggested that various aspects of food products may explain their inhibitory effect, including pH, and ascorbic acid, lycopene, and ␤-carotene contents. Tomato and tomato-based products are the predominant sources of lycopene and one of the major sources of ascorbic acid in some populations.
Reactive oxygen compounds may contribute to prostate carcinogenesis (119, 120) . Prostate epithelial cells in many men at the age of risk for prostate cancer are likely to be exposed to inflammatory-related reactive oxygen species because of the high prevalence of prostatitis. However, whether an antioxidant property accounts for the apparent benefit of tomato product consumption on prostate cancer risk remains unproven.
If oxidation proves critical to carcinogenesis, the dietary contribution to antioxidation is likely to be immensely complex. Synergy among antioxidants exists in experimental systems (121) , and synergistic effects are likely to be more complex in vivo. For example, synergy between ␣-tocopherol and ascorbic acid is well established (121) , resulting from the ability of ascorbic acid to reduce ␣-tocopheroxyl radicals, thereby recycling ␣-tocopherol. Complex synergistic effects may occur as a result of such direct interactions (e.g., recycling), different abilities of antioxidants to scavenge the various reactive oxygen species thus enhancing overall protection (103) , and the localization of different antioxidants in diverse subcellular compartments. Possibly, the benefits of tomatoes may result from the complex interaction of various carotenoids, ascorbic acid, and other antioxidant polyphenolic compounds.
Although the notion that lycopene may exert its role in humans through limiting cellular macromolecule damage from reactive oxygen species is appealing, other mechanisms may be operative. In addition, preliminary in vitro evidence indicates that lycopene reduces cellular proliferation of various cancer cell lines induced by insulin-like growth factor-I (IGF-I) (85) . This finding, which requires confirmation, is intriguing, given recent evidence that the circulating level of IGF-I is positively associated with higher risk of various cancers, including prostate cancer (122) . Various other potential mechanisms have been postulated (100, 108, 123, 124) . Most of the mechanistic data have been based on in vitro studies, but a recent study (125) found that supplementation with tomato products, as well as carrot and spinach products, resulted in a marked decrease in endogenous levels of strand breaks in lymphocyte DNA. More human studies are clearly needed.
CONCLUSIONS
Intake of tomatoes and tomato-based products and plasma levels of lycopene, a carotenoid found predominantly in tomatoes, have been relatively consistently associated with a lower risk of a variety of cancers. Evidence is strongest for cancers of the lung, stomach, and prostate gland and is suggestive for cancers of the cervix, breast, oral cavity, pancreas, colorectum, and esophagus. A large body of evidence also indicates that other fruits and vegetables may have additional or complementary benefits (3) (4) (5) . The likelihood that the associations between increased consumption of tomato and tomato-based products and lower risk for several cancer sites are causal is supported by the consistency of evidence by study design (ecologic, case-control, and prospective) and by exposure assessment (dietary-based and plasma-based) and by the unlikelihood that biases or uncontrolled confounding could plausibly account for all these associations in diverse populations. These findings add further support to current dietary recommendations to increase consumption of fruits and vegetables to reduce cancer risk.
The benefits of tomatoes and tomato products are often attributed to the carotenoid lycopene. However, a direct benefit of lycopene has not been proven, and other compounds in tomatoes alone or interacting with lycopene may be important. It is critical to recognize that the current evidence regarding dietary intake and lycopene blood concentrations reflects consumption of tomatoes and tomato products rather than purified lycopene supplements. The pharmacokinetic properties of lycopene remain poorly understood, and it is premature to recommend use of pharmacologic doses of lycopene for any health benefit. Further research on the bioavailability, pharmacology, and biology of this potentially important carotenoid is clearly warranted. Until more definitive data regarding specific benefits of purified forms of lycopene are available, current recommendations should emphasize the health benefits of diets rich in a variety of fruits and vegetables, including tomatoes and tomato-based products.
